EXPERT
De resultaten van deze studie kunnen een impact hebben op de manier waarop 2 op de 5 vrouwen met borstkanker worden behandeld.
The results of the EXPERT academic study could influence how 2 in 5 women with breast cancer are treated by identifying which women could be spared unnecessary radiation therapy after surgery in the future.
Deel deze pagina
The EXPERT academic study – which will involve 1,170 women from 90 hospitals and breast cancer centres linked to 8 groups from 8 countries around the globe – aims to better analyse the risk profile of breast cancer tumours in order to identify which women could be spared radiation therapy in the future. This study is coordinated and sponsored by the Breast Cancer Trials – Australia & New Zealand (BCT-ANZ) in collaboration with BIG.
Bestralingen in combinatie met hormoontherapie is momenteel de standaardbehandeling voor veel patiënten met beginnende borstkanker die een borstkankeroperatie ondergaan. Het werkelijke positieve effect van bestralingen kan echter aanzienlijk verschillen van patiënt tot patiënt, en patiënten met een laag risico op herval kunnen overbehandeld worden en onnodig aan bijwerkingen worden blootgesteld.
The prospect of safely de-escalating radiation therapy is of great interest to many patients, who will appreciate not being subjected to a treatment that will not benefit them significantly if their tumours are low-risk, while ensuring that patients at greater risk of relapse do receive treatment of an appropriate intensity.
